Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 20/20 | 0.87 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.79 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.62 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.61 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3973561 | 1.00 | DPP4 (0.87) | DPP4CHRM1KCNH2CHRM2CHRM3 | |
| SCHEMBL3968087 | 0.98 | DPP4 (0.88) | DPP4CHRM1KCNH2CHRM2CHRM3 | |
| SCHEMBL3968083 | 0.98 | DPP4 (0.88) | DPP4CHRM1KCNH2CHRM2CHRM3 | |
| SCHEMBL637608 | 0.93 | DPP4 (1.00) | DPP4CHRM1KCNH2 | |
| SCHEMBL637607 | 0.93 | DPP4 (1.00) | DPP4CHRM1KCNH2 | |
| SCHEMBL637749 | 0.92 | DPP4 (0.87) | DPP4CHRM1KCNH2CHRM2CHRM3 | |
| SCHEMBL639692 | 0.92 | DPP4 (0.87) | DPP4CHRM1KCNH2CHRM2CHRM3 | |
| SCHEMBL637748 | 0.92 | DPP4 (0.87) | DPP4CHRM1KCNH2CHRM2CHRM3 | |
| SCHEMBL639693 | 0.92 | DPP4 (0.87) | DPP4CHRM1KCNH2CHRM2CHRM3 | |
| SCHEMBL638695 | 0.91 | DPP4 (0.86) | DPP4CHRM1KCNH2CHRM2CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8697868-B2 | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-04-15 | — | — | US | disclosed |
| US-20090137801-A1 | 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-05-28 | — | — | US | disclosed |
| US-7501426-B2 | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2009-03-10 | — | — | US | disclosed |
| US-20050234108-A1 | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090137801-A1 | 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THEIR PREPARATION AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS | DPP8, DPP4, DPP7 | DPP4 2/4885CHRM1 1139/4885KCNH2 2691/4885 |
| US-20050234108-A1 | 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions | DPP8, DPP4, DPP7 | DPP4 2/4885CHRM1 1003/4885KCNH2 2546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.